Square Pharma Reports 6.43% Year-on-Year Profit Growth Despite High Import Costs

Square Pharmaceuticals has reported a 6.43% year-on-year growth in profit, reaching Tk 10.23 billion in the first half of the fiscal year 2024 despite facing high import costs. The company’s revenue also increased by 15% during the period, but higher…